Advertisement
The Essential Resource for the Medical Design Engineering Community
Subscribe to MDT Magazine All

Watson Launches Generic Exelon®

July 1, 2010 8:34 am | by Bio-Medicine.Org | News | Comments

MORRISTOWN, N.J. , July 1 /- Watson Pharmaceuticals, Inc. (NYSE: WPI ) announced today that, under a settlement with Novartis Pharmaceuticals Corporation, Novartis Pharma AG, Novartis AG, Novartis International Pharmaceutical Ltd., and Proterra AG (collectively "Novartis"), Watson has...

TOPICS:

Physicians See New Benefits, Treatment Opportunities for Brain Cancer with Elekta's Leksell Gamma Knife Perfexion

July 1, 2010 8:34 am | by Bio-Medicine.Org | News | Comments

ATLANTA , July 1 /- The refinements in Elekta's Gamma Knife ® surgery technology that created the fifth generation Leksell Gamma Knife® Perfexion™ are radically changing the approach to treating brain metastases and other brain disorders. With Perfexion, physicians are...

TOPICS:

NeoStem Adds Distinguished Researcher to its World-Class Scientific Advisory Board

July 1, 2010 8:34 am | by Bio-Medicine.Org | News | Comments

NEW YORK , July 1 /PRNewswire-Asia-FirstCall/ -- NeoStem, Inc. (NYSE Amex: NBS ) ("NeoStem" or the "Company"), an international biopharmaceutical company with operations in the U.S. and China , today announced that it has appointed Roberto Bolli , M.D., to its Scientific Advisory Board....

TOPICS:
Advertisement

Sector Snap: Home Health Care stocks tumble

July 1, 2010 7:45 am | by The Associated Press | News | Comments

Shares of home health providers fell Thursday as the Securities and Exchange Commission formally opened an investigation into potential medicare billing fraud at Amedisys Inc. and Almost Family Inc.Amedisys said it received a subpoena for documents relating to a Senate Finance Committee...

Amedisys under Medicare billing investigation

July 1, 2010 6:45 am | by The Associated Press | News | Comments

Home health provider Amedisys Inc. said Thursday it is being investigated by the Securities and Exchange Commission over Medicare billing.The company said it received a subpoena for documents relating to a Senate Finance Committee investigation. Amedisys said it plans to cooperate with the...

FUISZ Announces Advances in Devices and Solid Dosage Form

July 1, 2010 5:35 am | by Bio-Medicine.Org | News | Comments

MIAMI , July 1 /- FUISZ today announced two medical technology advances. First, FUISZ announced that it has received a notice of issuance from the United States Patent and Trademark Office for patent claims that cover a direct connection between prescribing physicians and blood analysis...

TOPICS:

Par Pharmaceutical Begins Shipment of Generic Zegerid®

July 1, 2010 5:35 am | by Bio-Medicine.Org | News | Comments

WOODCLIFF LAKE, N.J. , July 1 /- Par Pharmaceutical Companies, Inc. (NYSE: PRX ) today announced that it began shipping the 20mg/1100mg and 40mg/1100mg strengths of omeprazole and sodium bicarbonate capsules to the trade. Omeprazole and sodium bicarbonate capsules are the generic version...

TOPICS:

FDA Approves Sagent Pharmaceuticals' Heparin Sodium Injection, USP

July 1, 2010 5:35 am | by Bio-Medicine.Org | News | Comments

SCHAUMBURG, Ill. , July 1 /- Sagent Pharmaceuticals, Inc., a privately held specialty pharmaceutical company, today announced that the U.S. Food and Drug Administration (FDA) has approved the Company's nine presentations of heparin sodium injection, USP. Heparin is a vital anticoagulant,...

TOPICS:
Advertisement

Roche and IBM Collaborate to Develop Nanopore-Based DNA Sequencing Technology

July 1, 2010 5:33 am | by IBM | News | Comments

YORKTOWN HEIGHTS, N.Y. and BRANFORD, Conn., July 1 /PRNewswire-FirstCall/ -- Roche (SIX: RO, ROG; OTCQX: RHHBY) and IBM (NYSE: IBM) announced today an agreement to develop a nanopore-based technology that will directly read and sequence human DNA quickly and efficiently. Focused on...

TOPICS:

Endo Pharmaceuticals Completes Next Step in Regulatory Process for FORTESTAâ„¢ for Men With Low Testosterone

July 1, 2010 12:33 am | by Bio-Medicine.Org | News | Comments

CHADDS FORD, Pa. , July 1 /- Endo Pharmaceuticals (Nasdaq: ENDP ) has submitted a complete response to the U.S. Food and Drug Administration (FDA) following the company's receipt of a Complete Response letter in October 2009 related to the New Drug Application (NDA) submission for...

TOPICS:

July/August 2010 Digital Edition

July 1, 2010 12:00 am | Digital Editions | Comments

Inside: Read about asking the right questions about high performance plastic from micromolding an MIS device in “The Critical Questions When Micromolding for an MIS Device,” from Mikrotech. Shared are professionals’ opinions on FDA review process and wireless medical technology. Additionally, read about lasers for orthopedics, 3D imaging, package testing, sensors, testing, and Petri dish diagnostics.

Stem-cell therapy may provide new approach to fight infection

June 30, 2010 10:33 pm | by EurekAlert | News | Comments

(Ottawa Hospital Research Institute) A new study shows that treatment with mesenchymal stem cells can triple survival rates in mice with sepsis, a deadly condition that can occur when an infection spreads throughout the body. The treatment reduced the damaging effects of...

TOPICS:

Planned home births associated with tripling of neonatal mortality rate vs. planned hospital births

June 30, 2010 10:33 pm | by EurekAlert | News | Comments

(Elsevier Health Sciences) In a study published online today by the American Journal of Obstetrics & Gynecology, researchers from Maine Medical Center, Portland, Maine, analyzed the results of multiple studies from around the world. They report that less medical intervention,...

TOPICS:

AAO-HNS releases consensus statement: diagnosis and management of nasal valve compromise

June 30, 2010 10:33 pm | by EurekAlert | News | Comments

(American Academy of Otolaryngology -- Head and Neck Surgery) Today, the American Academy of Otolaryngology - Head and Neck Surgery (AAO-HNS) announced the release of a consensus statement to address ambiguities and disparities in the diagnosis and management of nasal valve compromise (NVC).

TOPICS:

Drug Device for Hearing Loss

June 30, 2010 8:38 pm | by Massachusetts Institute of Technology | News | Comments

An implant could deliver drugs directly to the cochlea.

Pages

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading